Monitoring laparoscopic radiofrequency renal lesions in real time using contrast-enhanced ultrasonography: An open-label, randomized, comparative pilot trial

Journal of Endourology

Volumn 27, Issue 6, 2013, Pages 697-704

  Chen, Yonghui ^a   Huang, Jiwei ^a   Xia, Lei ^a   Dong, Baijun ^a   Chen, Wei ^a   Xue, Wei ^a   Liu, Dongming ^a   Huang, Yiran ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CATHETER ABLATION; CONTRAST MEDIA; FEMALE; HUMANS; KIDNEY NEOPLASMS; LAPAROSCOPY; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PHOSPHOLIPIDS; PILOT PROJECTS; PROSPECTIVE STUDIES; SULFUR HEXAFLUORIDE;

EID: 84878592810     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2012.0694     Document Type: Article

References (25)

1. CarrawayWA, Raman JD, Cadeddu JA. Current status of renal radiofrequency ablation. Curr Opin Urol 2009;19:143-147
2. Mues AC, Landman J. Image-guided percutaneous ablation of renal tumors: Outcomes, technique, and application in urologic practice. Curr Urol Rep 2010;11:8-14
3. Bensalah K, Zeltser I, Tuncel A, et al. Evaluation of costs and morbidity associated with laparoscopic radiofrequency ablation and laparoscopic partial nephrectomy for treating small renal tumours. BJU Int 2008;101:467-471
4. Park S, Anderson JK, Matsumoto ED, et al. Radiofrequency ablation of renal tumors: Intermediate-Term results. J Endourol 2006;20:569-573
5. Castle SM, Gorbatiy V, Ekwenna O, Leveillee RJ. Laparoscopic and image-guided radiofrequency ablation of renal tumors: Patient selection and outcomes. Curr Urol Rep 2011;12:100-106
6. Abdellaoui A, Watkinson AF. Radiofrequency ablation of renal tumors. Future Oncol 2008;4:103-111
7. Meloni MF, Bertolotto M, Alberzoni C, et al. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: Contrast-enhanced sonography versus contrastenhanced CT or MRI. AJR Am J Roentgenol 2008;191: 1233-1238
8. Goldberg SN, Grassi CJ, Cardella JF, et al; Society of Interventional Radiology Technology Assessment Committee; International Working Group on Image-Guided Tumor Ablation. Image-guided tumor ablation: Standardization of terminology and reporting criteria. Radiology 2005;235: 728-739
9. Gervais DA, Kalva S, Thabet A. Percutaneous imageguided therapy of intra-Abdominal malignancy: Imaging evaluation of treatment response. Abdom Imaging 2009;34: 593-609
10. Wingo MS, Leveillee RJ. Central and deep renal tumors can be effectively ablated: Radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring. J Endourol 2008;22:1261-1267
11. Cosgrove D. Ultrasound contrast agents: An overview. Eur J Radiol 2006;60:324-330
12. Setola SV, Catalano O, Sandomenico F, Siani A. Contrastenhanced sonography of the kidney. Abdom Imaging 2007;32:21-28
13. Kong WT, Zhang WW, Guo HQ, et al. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: Is it sufficient for assessment of therapeutic response? Abdom Imaging 2011;36: 342-347
14. Slabaugh TK, Machaidze Z, Hennigar R, Ogan K. Monitoring radiofrequency renal lesions in real time using contrastenhanced ultrasonography: A porcine model. J Endourol 2005;19:579-583
15. Johnson DB, Duchene DA, Taylor GD, et al. Contrastenhanced ultrasound evaluation of radiofrequency ablation of the kidney: Reliable imaging of the thermolesion. J Endourol 2005;19:248-252
16. Margulis V, Matsumoto ED, Lindberg G, et al. Acute histologic effects of temperature-based radiofrequency ablation on renal tumor pathologic interpretation. Urology 2004; 64:660-663
17. Ascenti G, Zimbaro G, Mazziotti S, et al. Contrast-enhanced power Doppler US in the diagnosis of renal pseudotumors. Eur Radiol 2001;11:2496-2499
18. Piscaglia F, Bolondi L; Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: Retrospective analysis of 23188 investigations. Ultrasound Med Biol 2008;32:1369-1375
19. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008. Ultraschall Med 2006;29:28-44
20. Gervais DA, McGovern GJ, Arellano RS, et al. Radiofrequency ablation of renal cell carcinoma: Part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005;185:64-71
21. Hegarty NJ, Gill IS, Desai MM, et al. Probe-Ablative nephronsparing surgery: Cryoablation versus radiofrequency ablation. Urology 2006;68(suppl 1):7-13
22. Ji C, Li X, Zhang S, et al. Laparoscopic radiofrequency ablation of renal tumors: 32-month mean follow-up results of 106 patients. Urology 2011;77:798-802
23. Carey RI, Leveillee RJ. First prize: Direct real-Time temperature monitoring for laparoscopic and CT-guided radiofrequency ablation of renal tumors between 3 and 5 cm. J Endourol 2007;21:807-813
24. Abouassaly R, Lane BR, Novick AC. Active surveillance of renal masses in elderly patients. J Urol 2008;180:505-509
25. Rosales JC, Haramis G, Moreno J, et al. Active surveillance for renal cortical neoplasms. J Urol 2010;183:1698-1702